Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177 Lu-Labeled Radiohapten
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.124.267685 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Brett A Vaughn und 20 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York. Hauptthemen laut MEDLINE: Radioimmunotherapy, Lutetium, Colorectal Neoplasms, Radioisotopes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York.
- Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Radiology, Weill Cornell Medicine, New York, New York.
- Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
Förderung
- NCI NIH HHS
Zitieren
APA
Vaughn, B. A., Lee, S. G., Vargas, D. B., Seo, S., Rinne, S. S., Xu, H., Guo, H. F., Le Roux, A. B., Gajecki, L., Krebs, S., Yang, G., Ouerfelli, O., Zanzonico, P. B., Fung, E. K., St Jean, S., Carrasco, S. E., Jungbluth, A., Cheung, N. K. V., Larson, S. M., …, & Cheal, S. M. (2024). Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177 Lu-Labeled Radiohapten. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267685
Vancouver
Vaughn BA, Lee SG, Vargas DB, Seo S, Rinne SS, Xu H, et al. Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177 Lu-Labeled Radiohapten. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267685
BibTeX
@article{Vaughn2024,
author = {Vaughn, Brett A and Lee, Sang-Gyu and Vargas, Daniela Burnes and Seo, Shin and Rinne, Sara S and Xu, Hong and Guo, Hong-Fen and Le Roux, Alexandre B and Gajecki, Leah and Krebs, Simone and Yang, Guangbin and Ouerfelli, Ouathek and Zanzonico, Pat B and Fung, Edward K and St Jean, Samantha and Carrasco, Sebastian E and Jungbluth, Achim and Cheung, Nai Kong V and Larson, Steven M and Veach, Darren R and Cheal, Sarah M},
title = {Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177 Lu-Labeled Radiohapten},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.124.267685}
}
EUVIMED